Services

We are here to help in anything you need. Please use our online system or send an email to .

Inhalation Preparation R&D Platform

Inhalation drug delivery is a method wherein medications are administered directly to the lungs. This route is particularly beneficial for treating respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary infections. Through direct delivery to the target site, inhalation therapy can offer faster onset of action, improved efficacy, and reduced systemic side effects compared to other delivery methods. Therefore, inhalation preparation has become an important part of numerous complex preparations. However, formulating drugs for inhalation involves unique challenges, such as ensuring particle size uniformity, stability, and delivering a therapeutically effective dose to the lungs. This requires not only knowledge of the physiology and anatomy of the respiratory system, but also extensive experience in formulation development and device design.

As a leading inhalation drug preparation R&D platform, we are dedicated to advancing the science behind inhalable medications. Our platform brings together expertise in pharmaceutical sciences, pulmonary medicine, and engineering to offer comprehensive services to support the development, optimization, and evaluation of inhalation drug preparations.

Our Inhalation Preparation R&D Platform

To support the development and optimization of inhalation drug preparation, our platform offers a comprehensive suite of services, including:

1. Inhalation Preparation Development and Optimization

We develop and optimize various inhalation drug preparations formulations, including:

Metered-dose inhalers (MDIs)
Nebulizers
Inhalers

Dry powder inhalers (DPIs)
Soft mist inhalers
Nasal inhalers

2. Inhalation Preparation Quality Research

Our platform encompasses rigorous testing to evaluate the physical and chemical properties of the formulations. We utilize cutting-edge analytical techniques to assess some special testing items such as:

Aerodynamic particle size distribution (APSD)
Delivered-dose uniformity (DDU)

Microparticle dose
Delivery rate and total delivered

3. Safety Evaluation of Inhalation Drug Administration

Our platform conducts thorough safety evaluations, including in vitro and in vivo studies, to assess the potential toxicity of the inhalation formulations. The testing items include:

Pharmacokinetic study
Acute toxicity study
Irritation study

Tissue distribution study
28-day repeated dose toxicity study
Allergy and other tests

Platform Instruments and Equipment

Our platform is equipped with state-of-the-art instruments and equipment to support inhalation drug research and development. This includes:

Particle size analyzers
Spray dryers and freeze dryers
Medicinal nebulizer

Cascade impactors
Stability chambers
Breathing simulator

Aerosol inhalation drug delivery device, including clean air generation system, aerosol generation system, real-time monitoring and control system for temperature, humidity, oxygen, carbon dioxide and other conventional gases, real-time sampling system, real-time adjustment system for test sample concentration, etc.

It should be noted that our service is only used for research, not for clinical use.

Inquiry